U.S. legalization

1 articles
The Motley FoolThe Motley Fool··Thomas Niel

Tilray Poised for Breakout as Cannabis Reform Becomes Make-or-Break Factor

Tilray shows improving fundamentals with 73% international growth and shrinking losses, but stock upside heavily dependent on U.S. cannabis rescheduling.
TLRYEBITDA growthinternational expansion